Study #PA16-1041
Quantification of tumor imaging kinetics and blood biomarkers in head and neck cancer patients
MD Anderson Study Status
Not Accepting
Treatment Agent
Description
The goal of this research study is to find out if using additional MRIs and biomarker testing can help researchers learn to predict how the tumor may change during radiation therapy. Biomarkers are found in the blood/tissue and may be related to participant's reaction to treatment. Biomarker testing in the study may include genetic biomarkers. This is an investigational study. MRIs on this study are performed using FDA-approved and commercially available methods. Having added scans and blood tests is investigational. Up to 100 participants will be enrolled in this study (up to 80 patients and up to 20 healthy volunteers in another part of the study). All will take part at MD Anderson.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Cutaneous Squamous Cell Carcinoma of the Head and Neck;Healthy Subject;Head and Neck Cancer
Study phase:
Not applicable
Physician name:
Clifton Fuller
Department:
Radiation Oncology
For general questions about clinical trials:
1-877-582-0066
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.